Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease.
about
Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model.Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins.
P2860
Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Development of a replication-d ...... nduced infections and disease.
@en
type
label
Development of a replication-d ...... nduced infections and disease.
@en
prefLabel
Development of a replication-d ...... nduced infections and disease.
@en
P2093
P2860
P50
P356
P1476
Development of a replication-d ...... nduced infections and disease.
@en
P2093
Gert Scheper
Hanneke Schuitemaker
Jan Serroyen
Jort Vellinga
Kerstin Wunderlich
Koen Oosterhuis
Leontien Bosch
Melissa Bhaggoe
Roland Zahn
Santusha Karia
P2860
P304
P356
10.1002/IJC.30679
P577
2017-03-06T00:00:00Z